EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Advances in metabolomics in critically ill patients with sepsis and septic shock

Swarnima Pandey

Clinical and Experimental Emergency Medicine · 19.07.2024 · 12 (1) · 4-15

DOI: 10.15441/ceem.24.211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Experimental Emergency Medicine, online erschienen am 19.07.2024. Verfasst von Swarnima Pandey. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is associated with high morbidity and mortality rates in hospitalized patients. This condition has a complex pathophysiology and can swiftly progress to the severe form of septic shock, which can lead to organ dysfunction, organ failure, and death. Metabolomics has transformed the clinical and research topography of sepsis, with application to prognosis, diagnosis, and risk assessment. Metabolomics involves detecting and analyzing levels of metabolites in blood (plasma, serum, and/or erythrocytes) and urine; when applied in sepsis, this technology can improve our understanding of the pathogenesis of the disease and aid in better disease management by identifying early biomarkers. For this review article, “metabolomics,” “sepsis,” and “septic shock” were keywords used to search records in various databases including PubMed and Scopus from their inception until December 2023. This review article summarizes information regarding metabolic profiling performed in sepsis and septic shock and illustrates how metabolomics is advancing the diagnosis and prognosis of patients with sepsis.

Schlagwörter

Stichwörter der Autor:innen

BiomarkersDiagnosisMetabolomicsSepsisSeptic shock

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA.

Zitieren

APA

Pandey, S. (2024). Advances in metabolomics in critically ill patients with sepsis and septic shock. Clinical and Experimental Emergency Medicine, 12(1), 4-15. https://doi.org/10.15441/ceem.24.211

Vancouver

Pandey S. Advances in metabolomics in critically ill patients with sepsis and septic shock. Clinical and Experimental Emergency Medicine. 2024;12(1):4-15. doi:10.15441/ceem.24.211

BibTeX
@article{Pandey2024,
  author = {Pandey, Swarnima},
  title = {Advances in metabolomics in critically ill patients with sepsis and septic shock},
  journal = {Clinical and Experimental Emergency Medicine},
  year = {2024},
  volume = {12},
  number = {1},
  pages = {4--15},
  doi = {10.15441/ceem.24.211}
}
Kostenlos starten →